Pyronaridine--a new antimalarial drug
Shao, B.R.
Zhonghua Nei Ke Za Zhi 24(11): 691-692
1985
ISSN/ISBN: 0578-1426 PMID: 3914406 Document Number: 247833
Document emailed within 1 workday
Related Documents
Adegoke, O.A.; Babalola, C.P.; Oshitade, O.S.; Famuyiwa, A.A. 2006: Determination of the physicochemical properties of pyronaridine - a new antimalarial drug Pakistan Journal of Pharmaceutical Sciences 19(1): 1-6Kamya, M.R.; Bakyaita, N.N.; Talisuna, A.O.; Were, W.M.; Staedke, S.G. 2002: Increasing antimalarial drug resistance in Uganda and revision of the national drug policy Tropical Medicine and International Health: Tm and Ih 7(12): 1031-1041
Mahomva, A.I.; Peterson, D.E.; Rakata, L. 1996: Does an antimalarial drug history mean anything? Central African Journal of Medicine 42(12): 345-346
Nau, J.-Y. 2010: A new antimalarial drug combination Revue Medicale Suisse 6(247): 942-943
Sonntag, A.C.; Stenger, V.G.; Vogh, B.P.; Maren, T.H. 1972: The pharmacology of the antimalarial drug 4,4'-diformamidodiphenylsulfone (DFD) in dog and monkey Journal of Pharmacology and Experimental Therapeutics 182(1): 34-47
Rudraraju, A.V.; Amoyaw, P.N.A.; Hubin, T.J.; Khan, M.O.F. 2014: Determination of log P values of new cyclen based antimalarial drug leads using RP-HPLC Die Pharmazie 69(9): 655-662
Anderson, T.J.C.; Roper, C. 2005: The origins and spread of antimalarial drug resistance: lessons for policy makers Acta Tropica 94(3): 269-280
Hatch, G.M.; Ross, T.K. 1998: The antimalarial drug chloroquine inhibits glycerol uptake into cardiac cells Proceedings of the Western Pharmacology Society 41: 21-24
Marino, M.T.; Peggins, J.O.; Brown, L.D.; Urquhart, M.R.; Brewer, T.G. 1994: Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511) Drug Metabolism and Disposition: the Biological Fate of Chemicals 22(3): 358-366
Vestergaard, L.S.; Ringwald, P. 2007: Responding to the challenge of antimalarial drug resistance by routine monitoring to update national malaria treatment policies American Journal of Tropical Medicine and Hygiene 77(6 Suppl): 153-159
Mbonye, A.K.; Magnussen, P. 2010: Symptom-based diagnosis of malaria and its implication on antimalarial drug use in pregnancy in Central Uganda: results from a community trial International Journal of Adolescent Medicine and Health 22(2): 257-262
Meremikwu, M.; Okomo, U.; Nwachukwu, C.; Oyo-Ita, A.; Eke-Njoku, J.; Okebe, J.; Oyo-Ita, E.; Garner, P. 2007: Antimalarial drug prescribing practice in private and public health facilities in South-east Nigeria: a descriptive study Malaria Journal 6: 55
Menard, D.; Djalle, D.; Yapou, F.; Manirakiza, A.; Talarmin, A. 2006: Frequency distribution of antimalarial drug-resistant alleles among isolates of Plasmodium falciparum in Bangui, Central African Republic American Journal of Tropical Medicine and Hygiene 74(2): 205-210
Nshakira, N.; Kristensen, M.; Ssali, F.; Whyte, S.Reynolds. 2002: Appropriate treatment of malaria? Use of antimalarial drugs for children's fevers in district medical units, drug shops and homes in eastern Uganda Tropical Medicine and International Health: Tm and Ih 7(4): 309-316
Feng, Z.; Wu, Z.F.; Wang, C.Y.; Jiang, N.X. 1987: Pharmacokinetics of pyronaridine in malaria patients Zhongguo Yao Li Xue Bao 8(6): 543-546
Chen, K.Y.; Ha, S.H.; Zhan, C.Q.; Shao, B.R. 1987: Sensitivities of different stages of erythrocytic Plasmodium falciparum to pyronaridine Zhongguo Yao Li Xue Bao 8(4): 348-351
Kawai, S.; Kano, S.; Chang, C.; Suzuki, M. 1996: The effects of pyronaridine on the morphology of Plasmodium falciparum in Aotus trivirgatus American Journal of Tropical Medicine and Hygiene 55(2): 223-229
Shao, B.R.; Ye, X.Y. 1986: Delay in emergence of resistance to pyronaridine phosphate in Plasmodium berghei Zhongguo Yao Li Xue Bao 7(5): 463-467
Chen, K.Y.; Shao, B.R.; Zhang, J.X.; Lin, B.Y. 1985: Therapeutic effect of pyronaridine given intragastrically on Plasmodium cynomolgi-infected rhesus monkeys Yao Xue Xue Bao 20(4): 309-311
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571